Avita Medical Ltd. ADS (AVMXY) News Nov 14, 2014,
Post# of 250675
Posted On: 11/17/2014 2:21:12 AM
Avita Medical Ltd. ADS (AVMXY) News Nov 14, 2014, 8:10 p.m.
MarketWatch News on AVMXY
No News currently available for AVMXY
Advertisement
Other News on AVMXY
Avita Medical: A Comprehensive Look At An Unknown Company With A Transcendent Technology 12:35 p.m. Oct. 7, 2014 - Seeking Alpha
Avita Med cleared to expand ReCell trial 11:55 a.m. Sept. 16, 2014 - Seeking Alpha
For Avita, 'NICE' Decision In September Could Be Huge 9:19 a.m. July 15, 2014 - Seeking Alpha
Positive Clinical And Commercial Updates From Avita Medical 9:27 a.m. March 27, 2014 - Seeking Alpha
4 Bold Biotech Calls For 2014 9:00 a.m. Dec. 26, 2013 - Seeking Alpha
Big Changes Coming To The Wound Care Market In 2014 10:08 a.m. Oct. 21, 2013 - Seeking Alpha
Tenet Cut to Underperform - Analyst Blog 3:20 p.m. Oct. 11, 2013 - Zacks.com
Tenet Closes Vanguard Acquisition - Analyst Blog 2:30 p.m. Oct. 3, 2013 - Zacks.com
Press Releases on AVMXY
UPDATE - Avita Medical Provides NICE Guidance Recommendation Update 5:04 p.m. Nov. 12, 2014 - Marketwired
Avita Medical Provides NICE Guidance Recommendation Update 1:11 p.m. Nov. 12, 2014 - Marketwired
Avita Medical Announces Receipt of $1.4 Million R&D Tax Incentive 5:31 a.m. Nov. 11, 2014 - Marketwired
Avita Medical Secures US FDA Approval to Modify ReCell(R) Clinical Burns Trial 11:26 a.m. Sept. 16, 2014 - Marketwire
Global Pharmaceutical Survey 2013-2014 - Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry 3:27 p.m. July 15, 2014 - PR Newswire - PRF
Avita Medical Presents More Positive ReCell Repigmentation Trial Results 8:30 a.m. June 11, 2014 - Marketwire
Translational Regenerative Medicine: Market Prospects 2014-2024 9:11 a.m. June 3, 2014 - PR Newswire - PRF
Avita Medical Appoints New Chairman 9:36 a.m. May 20, 2014 - Marketwire
ReCell(R) Spray-on Skin(R) Demonstrates Superior Results Treating Hypopigmentation in Aesthetic Plastic Surgery Trial 8:31 a.m. May 15, 2014 - Marketwire
United States Food and Drug Administration Grants an Investigational Device Exemption for Compassionate Use of ReCell 8:31 a.m. April 10, 2014 - Marketwire
ReCell Containing Ambient-Stored Enzyme Launched in United Kingdom and Europe 12:11 p.m. April 8, 2014 - Marketwire
Translational Regenerative Medicine: Market Prospects 2014-2024 11:35 a.m. Feb. 27, 2014 - PR Newswire - PRF
Translational Regenerative Medicine: Market Prospects 2014-2024 10:11 a.m. Feb. 12, 2014 - PR Newswire - PRF
Avita Medical: Update to Shareholders 9:03 a.m. Dec. 11, 2013 - Marketwire
Avita Medical Announces Positive Interim Clinical Study Results on Restoration of Pigment in Burn Scars at Clinical Cosmetic & Reconstructive Expo 8:01 a.m. Oct. 18, 2013 - Marketwire
Avita Medical to Present at 2013 Stem Cell Meeting on the Mesa 11:23 a.m. Oct. 9, 2013 - Marketwire
Avita Medical Announces Completion of Enrollment in ReCell(R) Trial for Vitiligo 7:01 a.m. Aug. 21, 2013 - Marketwire
Avita Medical Enrolls First Patients in ReCell(R) Trial for Chronic Leg Ulcers 8:30 a.m. Aug. 1, 2013 - Marketwire
MarketWatch News on AVMXY
No News currently available for AVMXY
Advertisement
Other News on AVMXY
Avita Medical: A Comprehensive Look At An Unknown Company With A Transcendent Technology 12:35 p.m. Oct. 7, 2014 - Seeking Alpha
Avita Med cleared to expand ReCell trial 11:55 a.m. Sept. 16, 2014 - Seeking Alpha
For Avita, 'NICE' Decision In September Could Be Huge 9:19 a.m. July 15, 2014 - Seeking Alpha
Positive Clinical And Commercial Updates From Avita Medical 9:27 a.m. March 27, 2014 - Seeking Alpha
4 Bold Biotech Calls For 2014 9:00 a.m. Dec. 26, 2013 - Seeking Alpha
Big Changes Coming To The Wound Care Market In 2014 10:08 a.m. Oct. 21, 2013 - Seeking Alpha
Tenet Cut to Underperform - Analyst Blog 3:20 p.m. Oct. 11, 2013 - Zacks.com
Tenet Closes Vanguard Acquisition - Analyst Blog 2:30 p.m. Oct. 3, 2013 - Zacks.com
Press Releases on AVMXY
UPDATE - Avita Medical Provides NICE Guidance Recommendation Update 5:04 p.m. Nov. 12, 2014 - Marketwired
Avita Medical Provides NICE Guidance Recommendation Update 1:11 p.m. Nov. 12, 2014 - Marketwired
Avita Medical Announces Receipt of $1.4 Million R&D Tax Incentive 5:31 a.m. Nov. 11, 2014 - Marketwired
Avita Medical Secures US FDA Approval to Modify ReCell(R) Clinical Burns Trial 11:26 a.m. Sept. 16, 2014 - Marketwire
Global Pharmaceutical Survey 2013-2014 - Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry 3:27 p.m. July 15, 2014 - PR Newswire - PRF
Avita Medical Presents More Positive ReCell Repigmentation Trial Results 8:30 a.m. June 11, 2014 - Marketwire
Translational Regenerative Medicine: Market Prospects 2014-2024 9:11 a.m. June 3, 2014 - PR Newswire - PRF
Avita Medical Appoints New Chairman 9:36 a.m. May 20, 2014 - Marketwire
ReCell(R) Spray-on Skin(R) Demonstrates Superior Results Treating Hypopigmentation in Aesthetic Plastic Surgery Trial 8:31 a.m. May 15, 2014 - Marketwire
United States Food and Drug Administration Grants an Investigational Device Exemption for Compassionate Use of ReCell 8:31 a.m. April 10, 2014 - Marketwire
ReCell Containing Ambient-Stored Enzyme Launched in United Kingdom and Europe 12:11 p.m. April 8, 2014 - Marketwire
Translational Regenerative Medicine: Market Prospects 2014-2024 11:35 a.m. Feb. 27, 2014 - PR Newswire - PRF
Translational Regenerative Medicine: Market Prospects 2014-2024 10:11 a.m. Feb. 12, 2014 - PR Newswire - PRF
Avita Medical: Update to Shareholders 9:03 a.m. Dec. 11, 2013 - Marketwire
Avita Medical Announces Positive Interim Clinical Study Results on Restoration of Pigment in Burn Scars at Clinical Cosmetic & Reconstructive Expo 8:01 a.m. Oct. 18, 2013 - Marketwire
Avita Medical to Present at 2013 Stem Cell Meeting on the Mesa 11:23 a.m. Oct. 9, 2013 - Marketwire
Avita Medical Announces Completion of Enrollment in ReCell(R) Trial for Vitiligo 7:01 a.m. Aug. 21, 2013 - Marketwire
Avita Medical Enrolls First Patients in ReCell(R) Trial for Chronic Leg Ulcers 8:30 a.m. Aug. 1, 2013 - Marketwire
(0)
(0)